Clinical Trial

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness due to minor eye irritations.
Protocol Amendment History 3 changes
critical Primary endpoint(s) modified 2026-06-11
notable Primary completion moved earlier: 2027-11 -> 2027-02 2026-05-05
minor Completion moved earlier: 2027-11 -> 2027-02 2026-05-05
Trial Details
NCT Number NCT07531043
Lead Sponsor Alcon Research
Conditions Ocular Hyperemia
Enrollment 230 participants
Start Date 2026-10
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-10